Orwah Al-Khalili, MD
Rheumatology · Peoria, AZNPI 1457666026
Payments from drug & device makers
Across 816 payments — averaging $24.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$4K
- AbbVie$4K
- Amgen$3K
- AstraZeneca$1K
- GSK$881
- Novartis$850
- plus $6K from 35 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 80 | $3,978 |
| AbbVie | 133 | $3,932 |
| Amgen(2 entities) | 142 | $2,732 |
| AstraZeneca(2 entities) | 59 | $1,292 |
| GSK | 41 | $881 |
| Novartis | 42 | $850 |
| Mallinckrodt Hospital Products Inc. | 34 | $812 |
| Johnson & Johnson | 51 | $786 |
| Radius Health, Inc. | 30 | $645 |
| Boehringer Ingelheim | 23 | $501 |
| Sanofi | 11 | $485 |
| E.r. Squibb & Sons, L.L.C. | 22 | $428 |
| Fresenius Kabi USA, LLC | 20 | $426 |
| Pfizer | 28 | $409 |
| ANI Pharmaceuticals, Inc. | 22 | $352 |
| Lilly USA, LLC | 14 | $248 |
| Actelion Pharmaceuticals US, Inc. | 9 | $234 |
| Sobi, Inc | 9 | $188 |
| Organon | 8 | $143 |
| Aurinia Pharma U.S., Inc. | 3 | $142 |
| Genentech USA, Inc. | 4 | $80 |
| Tersera Therapeutics LLC | 4 | $74 |
| Kiniksa Pharmaceuticals, Ltd. | 4 | $70 |
| Kyowa Kirin, Inc. | 2 | $55 |
| Celltrion USA Inc. | 2 | $44 |
| Merck | 2 | $43 |
| Octapharma USA, Inc. | 1 | $42 |
| Arcutis Biotherapeutics, Inc. | 2 | $39 |
| Hikma Pharmaceuticals USA | 2 | $30 |
| Biogen | 1 | $27 |
| Bioventus LLC | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Sandoz | 1 | $19 |
| Scilex Pharmaceuticals Inc. | 1 | $18 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $18 |
| Nevro Corp. | 1 | $15 |
| Bayer | 1 | $15 |
| Mylan Institutional Inc. | 1 | $14 |
| Abbott | 1 | $14 |
| Avanos Medical | 1 | $14 |
| Qiagen, LLC | 1 | $13 |
How this compares
$20,147 in reported general payments places this provider in the 60th percentile of 102 rheumatology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Peoria
- Joy SchechtmanPeoria$2.1M
- Varun BhallaPeoria$7K
- Ravi BhallaPeoria$5K
- Mona AminGlendale$5.5M
- Nehad SolomanPhoenix$4.8M
- John TesserPhoenix$4.8M
- Joon Hee LimGilbert$4.5M
- Andrew SharobeemGlendale$4M
- Swati BharadwajPhoenix$3.4M
- Amer Al-KhoudariChandler$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.